BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38704585)

  • 21. Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease.
    Kono M; Miyashita K; Hirama R; Oshima Y; Takeda K; Mochizuka Y; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Suda T; Nakamura H
    Respir Med; 2021 Sep; 186():106534. PubMed ID: 34260978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-type lectin Mincle initiates IL-17-mediated inflammation in acute exacerbations of idiopathic pulmonary fibrosis.
    Tao C; Xian H; Nian-Yu Z; Jia-Cui S; Dong W; Hui-Ping L
    Biomed Pharmacother; 2023 Mar; 159():114253. PubMed ID: 36680813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GLUT1-dependent glycolysis regulates exacerbation of fibrosis via AIM2 inflammasome activation.
    Cho SJ; Moon JS; Nikahira K; Yun HS; Harris R; Hong KS; Huang H; Choi AMK; Stout-Delgado H
    Thorax; 2020 Mar; 75(3):227-236. PubMed ID: 31822523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary fibrosis model of mice induced by different administration methods of bleomycin.
    Gul A; Yang F; Xie C; Du W; Mohammadtursun N; Wang B; Le J; Dong J
    BMC Pulm Med; 2023 Mar; 23(1):91. PubMed ID: 36944966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MFAP4: a candidate biomarker for hepatic and pulmonary fibrosis?
    Mölleken C; Poschmann G; Bonella F; Costabel U; Sitek B; Stühler K; Meyer HE; Schmiegel WH; Marcussen N; Helmer M; Nielsen O; Hansen S; Schlosser A; Holmskov U; Sorensen GL
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Mar; 33(1):41-50. PubMed ID: 27055835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alveolar epithelial TET2 is not involved in the development of bleomycin-induced pulmonary fibrosis.
    Qin W; Crestani B; Spek CA; Scicluna BP; van der Poll T; Duitman J
    FASEB J; 2021 May; 35(5):e21599. PubMed ID: 33913570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased expression of OPN contributes to idiopathic pulmonary fibrosis and indicates a poor prognosis.
    Ji J; Zheng S; Liu Y; Xie T; Zhu X; Nie Y; Shen Y; Han X
    J Transl Med; 2023 Sep; 21(1):640. PubMed ID: 37726818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LTBP2 is secreted from lung myofibroblasts and is a potential biomarker for idiopathic pulmonary fibrosis.
    Enomoto Y; Matsushima S; Shibata K; Aoshima Y; Yagi H; Meguro S; Kawasaki H; Kosugi I; Fujisawa T; Enomoto N; Inui N; Nakamura Y; Suda T; Iwashita T
    Clin Sci (Lond); 2018 Jul; 132(14):1565-1580. PubMed ID: 30006483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transmembrane protease, serine 4 (TMPRSS4) is upregulated in IPF lungs and increases the fibrotic response in bleomycin-induced lung injury.
    Valero-Jiménez A; Zúñiga J; Cisneros J; Becerril C; Salgado A; Checa M; Buendía-Roldán I; Mendoza-Milla C; Gaxiola M; Pardo A; Selman M
    PLoS One; 2018; 13(3):e0192963. PubMed ID: 29529050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. S100A12 as Biomarker of Disease Severity and Prognosis in Patients With Idiopathic Pulmonary Fibrosis.
    Li Y; He Y; Chen S; Wang Q; Yang Y; Shen D; Ma J; Wen Z; Ning S; Chen H
    Front Immunol; 2022; 13():810338. PubMed ID: 35185901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amelioration of bleomycin-induced pulmonary fibrosis in a mouse model by a combination therapy of bosentan and imatinib.
    Chilakapati SR; Serasanambati M; Vissavajjhala P; Kanala JR; Chilakapati DR
    Exp Lung Res; 2015 May; 41(4):173-88. PubMed ID: 25844688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.
    Kim TH; Lee YH; Kim KH; Lee SH; Cha JY; Shin EK; Jung S; Jang AS; Park SW; Uh ST; Kim YH; Park JS; Sin HG; Youm W; Koh ES; Cho SY; Paik YK; Rhim TY; Park CS
    Am J Respir Crit Care Med; 2010 Sep; 182(5):633-42. PubMed ID: 20463180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secretory leukocyte protease inhibitor gene deletion alters bleomycin-induced lung injury, but not development of pulmonary fibrosis.
    Habgood AN; Tatler AL; Porte J; Wahl SM; Laurent GJ; John AE; Johnson SR; Jenkins G
    Lab Invest; 2016 Jun; 96(6):623-31. PubMed ID: 26974397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High S100A9 level predicts poor survival, and the S100A9 inhibitor paquinimod is a candidate for treating idiopathic pulmonary fibrosis.
    Miura S; Iwamoto H; Namba M; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N
    BMJ Open Respir Res; 2024 Feb; 11(1):. PubMed ID: 38378778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 8-isoprostane levels in serum and bronchoalveolar lavage in idiopathic pulmonary fibrosis and sarcoidosis.
    Malli F; Bardaka F; Tsilioni I; Karetsi E; Gourgoulianis KI; Daniil Z
    Food Chem Toxicol; 2013 Nov; 61():160-3. PubMed ID: 23702326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis.
    Barnes JW; Duncan D; Helton S; Hutcheson S; Kurundkar D; Logsdon NJ; Locy M; Garth J; Denson R; Farver C; Vo HT; King G; Kentrup D; Faul C; Kulkarni T; De Andrade JA; Yu Z; Matalon S; Thannickal VJ; Krick S
    Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L141-L154. PubMed ID: 31042083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A New Model of Acute Exacerbation of Experimental Pulmonary Fibrosis in Mice.
    Yegen CH; Haine L; Da Costa Ferreira K; Marchant D; Bernaudin JF; Planès C; Voituron N; Boncoeur E
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intratracheal bleomycin causes airway remodeling and airflow obstruction in mice.
    Polosukhin VV; Degryse AL; Newcomb DC; Jones BR; Ware LB; Lee JW; Loyd JE; Blackwell TS; Lawson WE
    Exp Lung Res; 2012 Apr; 38(3):135-46. PubMed ID: 22394287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pirfenidone attenuates bleomycin-induced pulmonary fibrosis in mice by regulating Nrf2/Bach1 equilibrium.
    Liu Y; Lu F; Kang L; Wang Z; Wang Y
    BMC Pulm Med; 2017 Apr; 17(1):63. PubMed ID: 28420366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Value of Serum Osteopontin in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
    Gui X; Qiu X; Xie M; Tian Y; Min C; Huang M; Hongyan W; Chen T; Zhang X; Chen J; Cao M; Cai H
    Biomed Res Int; 2020; 2020():3424208. PubMed ID: 32104688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.